Rectal Cancer
Conditions
Keywords
Robotic Surgery, Rectal Cancer, Low anterior Resection, Abdominoperineal rectal extirpation, Economic analysis
Brief summary
Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.
Detailed description
Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel. To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.
Interventions
Robotic rectal resection, either sphincter preserving or extirpation
Sponsors
Study design
Eligibility
Inclusion criteria
* 18y * histologically proven rectal cancer with curative therapeutic approach * suitable for minimally-invasive surgery
Exclusion criteria
* no rectal cancer * primary open surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Costs of treatment | 1 year | costs caused by the case |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Major Complication | 30 days postoperatively | Clavin Dindo Score ≥ 3 |
| Length of Hospital Stay | 3 months | Hospital Stay after Surgery |
| 30-days Readmission | 30 days | Readmission within 30 days after Surgery |
Countries
Germany